Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study.

Wasat MansoorHendrik-Tobias ArkenauMaria AlsinaKohei ShitaraPeter Thuss-PatienceSinead CuffeMikhail DvorkinDavid ParkTakayuki AndoMarc Van Den EyndeGiordano D BerettaAlberto ZaniboniToshihiko DoiJosep TaberneroDavid H IlsonLukas MakrisKarim A BenhadjiEric Van Cutsem

Published in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2021)

As in patients with GC, FTD/TPI showed an efficacy benefit in patients with GEJC in the TAGS trial, along with demonstrating a manageable safety profile.

Keyphrases

metastatic colorectal cancer
phase iii
papillary thyroid
study protocol
randomized controlled trial
squamous cell carcinoma
phase ii
childhood cancer
gas chromatography
tandem mass spectrometry
liquid chromatography